Skip to main content
Premium Trial:

Request an Annual Quote

PierianDx: Mark McDonough

PierianDx has hired Mark McDonough as CEO. McDonough, who has also joined the company's board of directors, takes over from Chairman and interim CEO Joe Boorady. The previous permanent CEO, Michael Sanderson, left PierianDx in April. McDonough previously was president and CEO of immunogenomics startup Immunis.AI. He also led CombiMatrix through that firm's 2017 acquisition by Invitae.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.